119 related articles for article (PubMed ID: 36546327)
21. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF-κB activation and recurrent dexamethasone administration fails to suppress it in vivo.
Jain S; Dash P; Minz AP; Satpathi S; Samal AG; Behera PK; Satpathi PS; Senapati S
Prostate; 2019 Feb; 79(2):168-182. PubMed ID: 30264470
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
24. Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation.
Guo Z; Xing Z; Cheng X; Fang Z; Jiang C; Su J; Zhou Z; Xu Z; Holmberg A; Nilsson S; Liu Z
PLoS One; 2015; 10(5):e0124292. PubMed ID: 26010447
[TBL] [Abstract][Full Text] [Related]
25. Ameliorative Effect of Structurally Divergent Oleanane Triterpenoid, 3-Epifriedelinol from
Majid M; Farhan A; Baig MW; Khan MT; Kamal Y; Hassan SSU; Bungau S; Haq IU
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615482
[TBL] [Abstract][Full Text] [Related]
26. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling.
Hafeez BB; Siddiqui IA; Asim M; Malik A; Afaq F; Adhami VM; Saleem M; Din M; Mukhtar H
Cancer Res; 2008 Oct; 68(20):8564-72. PubMed ID: 18922932
[TBL] [Abstract][Full Text] [Related]
27. Astragaloside IV enhanced carboplatin sensitivity in prostate cancer by suppressing AKT/NF-κB signaling pathway.
He Y; Zhang Q; Chen H; Guo Q; Zhang L; Zhang Z; Li Y
Biochem Cell Biol; 2021 Apr; 99(2):214-222. PubMed ID: 32813978
[TBL] [Abstract][Full Text] [Related]
28. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.
Baci D; Bruno A; Cascini C; Gallazzi M; Mortara L; Sessa F; Pelosi G; Albini A; Noonan DM
J Exp Clin Cancer Res; 2019 Nov; 38(1):464. PubMed ID: 31718684
[TBL] [Abstract][Full Text] [Related]
29. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
30. Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer.
Nishimura K; Nonomura N; Satoh E; Harada Y; Nakayama M; Tokizane T; Fukui T; Ono Y; Inoue H; Shin M; Tsujimoto Y; Takayama H; Aozasa K; Okuyama A
J Natl Cancer Inst; 2001 Nov; 93(22):1739-46. PubMed ID: 11717335
[TBL] [Abstract][Full Text] [Related]
31. Endolysosomal ion channel MCOLN2 (Mucolipin-2) promotes prostate cancer progression via IL-1β/NF-κB pathway.
Yu H; Xie M; Meng Z; Lo CY; Chan FL; Jiang L; Meng X; Yao X
Br J Cancer; 2021 Nov; 125(10):1420-1431. PubMed ID: 34548638
[TBL] [Abstract][Full Text] [Related]
32. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
Debelec-Butuner B; Alapinar C; Varisli L; Erbaykent-Tepedelen B; Hamid SM; Gonen-Korkmaz C; Korkmaz KS
Mol Carcinog; 2014 Feb; 53(2):85-97. PubMed ID: 22911881
[TBL] [Abstract][Full Text] [Related]
33. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
Shanmugam MK; Rajendran P; Li F; Nema T; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Ho PC; Hui KM; Sethi G
J Mol Med (Berl); 2011 Jul; 89(7):713-27. PubMed ID: 21465181
[TBL] [Abstract][Full Text] [Related]
34. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
Narayanan BA; Narayanan NK; Pittman B; Reddy BS
Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
[TBL] [Abstract][Full Text] [Related]
35. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA
Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277
[TBL] [Abstract][Full Text] [Related]
36. Relationship between IL-6/ERK and NF-κB: a study in normal and pathological human prostate gland.
Rodríguez-Berriguete G; Prieto A; Fraile B; Bouraoui Y; de Bethencourt FR; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
Eur Cytokine Netw; 2010 Dec; 21(4):241-50. PubMed ID: 21081304
[TBL] [Abstract][Full Text] [Related]
37. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
[TBL] [Abstract][Full Text] [Related]
38. Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.
Zhang Y; Lapidus RG; Liu P; Choi EY; Adediran S; Hussain A; Wang X; Liu X; Dan HC
Mol Cancer Ther; 2016 Jul; 15(7):1504-14. PubMed ID: 27196761
[TBL] [Abstract][Full Text] [Related]
39. Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells.
Assar EA; Vidalle MC; Chopra M; Hafizi S
Tumour Biol; 2016 Jul; 37(7):9375-85. PubMed ID: 26779636
[TBL] [Abstract][Full Text] [Related]
40. IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression.
Péant B; Gilbert S; Le Page C; Poisson A; L'Ecuyer E; Boudhraa Z; Bienz MN; Delvoye N; Saad F; Mes-Masson AM
Oncotarget; 2017 Feb; 8(9):14487-14501. PubMed ID: 27577074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]